Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239,597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations.
Liu N, Yu M, Yin T, Jiang Y, Liao X, Tang J, Li Y, Qin D, Li D, Wang Y. Liu N, et al. Among authors: li d, li y. Signal Transduct Target Ther. 2020 May 27;5(1):63. doi: 10.1038/s41392-020-0161-7. Signal Transduct Target Ther. 2020. PMID: 32457345 Free PMC article. No abstract available.
Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes.
Zou B, Li T, Zhou Q, Ma D, Chen Y, Huang M, Peng F, Xu Y, Zhu J, Ding Z, Zhou L, Wang J, Ren L, Yu M, Gong Y, Li Y, Chen L, Lu Y. Zou B, et al. Among authors: li t, li y. Medicine (Baltimore). 2016 Apr;95(17):e3507. doi: 10.1097/MD.0000000000003507. Medicine (Baltimore). 2016. PMID: 27124057 Free PMC article.
Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports.
Liu Y, Zhang Y, Zhang L, Liu B, Wang Y, Zhou X, Li Y, Zhao Q, Gong Y, Zhou L, Zhu J, Ding Z, Wang J, Peng F, Huang M, Li L, Ren L, Lu Y. Liu Y, et al. Among authors: li y, li l. Oncotarget. 2017 Jul 25;8(30):49680-49688. doi: 10.18632/oncotarget.17915. Oncotarget. 2017. PMID: 28591695 Free PMC article.
Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.
Hu B, Zhou X, Liu Y, Li Q, Xiang M, Zou B, Peng F, Huang M, Gong Y, Zhu J, Wang Y, Ren L, Xu Y, Zhang Y, Li Y, Yu M, Xue J, Deng L, Wang J, Ding Z, Lu Y. Hu B, et al. Among authors: li y, li q. Oncol Lett. 2018 Apr;15(4):5671-5679. doi: 10.3892/ol.2018.8064. Epub 2018 Feb 15. Oncol Lett. 2018. PMID: 29556304 Free PMC article.
Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters.
Tang X, Li Y, Tian X, Zhou X, Wang Y, Huang M, Ren L, Zhou L, Xue J, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. Tang X, et al. Among authors: li y. Radiother Oncol. 2019 Mar;132:197-203. doi: 10.1016/j.radonc.2018.10.016. Epub 2018 Oct 29. Radiother Oncol. 2019. PMID: 30385172
239,597 results
You have reached the last available page of results. Please see the User Guide for more information.